NCT05968807 iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
| NCT ID | NCT05968807 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hospital for Sick Children |
| Condition | Solid Organ Transplant |
| Study Type | INTERVENTIONAL |
| Enrollment | 55 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2026-06-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 55 participants in total. It began in 2023-08-01 with a primary completion date of 2026-06-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The iParent2Parent (iP2P) program is a new, innovative virtual mentorship program that will connect parents one-to-one with other parents of pediatric solid organ transplant (SOT) recipients who are trained to offer vital peer support and mentorship. Parents of children who received a SOT at The Hospital for Sick Children will be invited to participate as mentors and mentees (randomized into the iP2P or control group). The iP2P program can decrease feelings of isolation, improve mental health and have a long-term positive impact on patient health. This research will increase our understanding of one-to-one peer support and leverage eHealth technologies to improve the access to and acceptability of parent peer support interventions.
Eligibility Criteria
Mentee Inclusion Criteria: * Parent of a patient under 18 years of age who received a solid organ transplant and is at least two months post-transplant, * Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and * English-speaking. Mentor Inclusion Criteria: * Parent of a patient under 21 years of age who received a solid organ transplant and is at least one year post-transplant, * Nominated by their child's healthcare team as a good candidate to act in the mentor role (e.g., good communication skills, positive adaptation and adjustment post-transplant, strong support network), * Access to a device (e.g., smart phone, tablet, computer) capable of using free WhatsApp software, and * English-speaking. Exclusion Criteria: * Non-English speaking.
Contact & Investigator
Samantha J. Anthony, PhD, MSW
PRINCIPAL INVESTIGATOR
The Hospital for Sick Children
Frequently Asked Questions
Who can join the NCT05968807 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Solid Organ Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05968807 currently recruiting?
Yes, NCT05968807 is actively recruiting participants. Contact the research team at samantha.anthony@sickkids.ca for enrollment information.
Where is the NCT05968807 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT05968807 clinical trial?
NCT05968807 is sponsored by The Hospital for Sick Children. The principal investigator is Samantha J. Anthony, PhD, MSW at The Hospital for Sick Children. The trial plans to enroll 55 participants.